Lisette G. de Pillis
Immunology · 2003–2006
A researcher in the Science corpus: 2 papers; trusts 5 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 5 citations into it
Whom Lisette G. de Pillis trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Lisette G. de Pillis overall
Papers from Lisette G. de Pillis's perspective
Ordered by how strongly the researchers Lisette G. de Pillis trusts endorse each paper. Same corpus, a different order for every researcher.
- Cancer immunotherapy: moving beyond current vaccines (Nature Medicine)
- Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity (Nature)
- Cancer Immunotherapy: A Treatment for the Masses (Science)
- The dynamics of an optimally controlled tumor model: A case study
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity (Journal of Experimental Medicine)
- T cell exhaustion (Nature Immunology)
- Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice (Journal of Experimental Medicine)
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer (New England Journal of Medicine)
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma (New England Journal of Medicine)
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
Their papers
- The dynamics of an optimally controlled tumor model: A case study (2003) — 411 citations
- Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations. (2006) — 598 citations